{"transactions":[{"id":747510,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:29:28.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":53250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in full on the earlier of the first anniversary of the date of grant or the 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":53250,"derivative":{"exercise_price":2.29,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":53250},"source":{"system":"sec-edgar","filing":"0001628280-26-041270","document":"wk-form4_1780691363.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000162828026041270/wk-form4_1780691363.xml","form_type":"4"}},{"id":747509,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:29:28.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in full on the earlier of the first anniversary of the date of grant or the 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":48300,"source":{"system":"sec-edgar","filing":"0001628280-26-041270","document":"wk-form4_1780691363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000162828026041270/wk-form4_1780691363.xml","form_type":"4"}},{"id":1120917,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-05T20:52:10.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":19500,"derivative":{"exercise_price":1.07,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001576885-25-000079","document":"wk-form4_1749156704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688525000079/wk-form4_1749156704.xml","form_type":"4"}},{"id":1120916,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:52:10.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual\nstockholder meeting, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":12800,"source":{"system":"sec-edgar","filing":"0001576885-25-000079","document":"wk-form4_1749156704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688525000079/wk-form4_1749156704.xml","form_type":"4"}},{"id":1484500,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:54:56.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 10, 2025 or the 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.62,"expiration_date":"2034-06-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001576885-24-000086","document":"wk-form4_1718052886.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688524000086/wk-form4_1718052886.xml","form_type":"4"}},{"id":1488140,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:25:40.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 4, 2025 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":195000,"derivative":{"exercise_price":0.664,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001415889-24-015760","document":"form4-06062024_080636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588924015760/form4-06062024_080636.xml","form_type":"4"}},{"id":1488139,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:25:40.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":150647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of (i) June 4, 2025 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":198485,"source":{"system":"sec-edgar","filing":"0001415889-24-015760","document":"form4-06062024_080636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588924015760/form4-06062024_080636.xml","form_type":"4"}},{"id":1801598,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-18T22:31:27.000Z","date":"2023-08-17","kind":"exercise","planned":true,"acquired":false,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.19,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":2800},"source":{"system":"sec-edgar","filing":"0001576885-23-000052","document":"wk-form4_1692397878.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688523000052/wk-form4_1692397878.xml","form_type":"4"}},{"id":1801597,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-18T22:31:27.000Z","date":"2023-08-17","kind":"exercise","planned":true,"acquired":false,"shares":39149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.72,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":39149},"source":{"system":"sec-edgar","filing":"0001576885-23-000052","document":"wk-form4_1692397878.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688523000052/wk-form4_1692397878.xml","form_type":"4"}},{"id":1801596,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T22:31:27.000Z","date":"2023-08-17","kind":"sale","planned":true,"acquired":false,"shares":2800,"price":6.66,"value":18648.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on May 17, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001576885-23-000052","document":"wk-form4_1692397878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688523000052/wk-form4_1692397878.xml","form_type":"4"}},{"id":1801595,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T22:31:27.000Z","date":"2023-08-17","kind":"exercise","planned":true,"acquired":true,"shares":2800,"price":1.19,"value":3332.0,"ownership":{"direct":true},"balance_after":2800,"source":{"system":"sec-edgar","filing":"0001576885-23-000052","document":"wk-form4_1692397878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688523000052/wk-form4_1692397878.xml","form_type":"4"}},{"id":1801594,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T22:31:27.000Z","date":"2023-08-17","kind":"sale","planned":true,"acquired":false,"shares":39149,"price":6.48,"value":253685.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on May 17, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001576885-23-000052","document":"wk-form4_1692397878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688523000052/wk-form4_1692397878.xml","form_type":"4"}},{"id":1801593,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T22:31:27.000Z","date":"2023-08-17","kind":"exercise","planned":true,"acquired":true,"shares":39149,"price":0.72,"value":28187.28,"ownership":{"direct":true},"balance_after":39149,"source":{"system":"sec-edgar","filing":"0001576885-23-000052","document":"wk-form4_1692397878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688523000052/wk-form4_1692397878.xml","form_type":"4"}},{"id":1863502,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-07T21:43:00.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 6, 2024 or the 2024 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":5.2,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001576885-23-000034","document":"wk-form4_1686174166.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688523000034/wk-form4_1686174166.xml","form_type":"4"}},{"id":1866475,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-05T20:33:22.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":44961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 1, 2024 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":44961,"derivative":{"exercise_price":3.09,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":44961},"source":{"system":"sec-edgar","filing":"0001209191-23-034327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919123034327/doc4.xml","form_type":"4"}},{"id":1866474,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T20:33:22.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":32362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest  on the earlier of (i) June 1, 2024 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":47838,"source":{"system":"sec-edgar","filing":"0001209191-23-034327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919123034327/doc4.xml","form_type":"4"}},{"id":2205152,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T21:16:11.000Z","date":"2022-07-15","kind":"sale","acquired":false,"shares":3600,"price":9.05,"value":32580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on June 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.97 to $9.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":15476,"source":{"system":"sec-edgar","filing":"0001209191-22-042606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919122042606/doc4.xml","form_type":"4"}},{"id":2226719,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T20:25:39.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on on the earlier of June 15, 2023 or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":3.59,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-037881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000120919122037881/doc4.xml","form_type":"4"}},{"id":2241511,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-06T21:51:34.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":16996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 2, 2023 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":16996,"derivative":{"exercise_price":8.42,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":16996},"source":{"system":"sec-edgar","filing":"0001209191-22-034626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919122034626/doc4.xml","form_type":"4"}},{"id":2241510,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-06T21:51:34.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":11876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest  on the earlier of (i) June 2, 2023 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":19076,"source":{"system":"sec-edgar","filing":"0001209191-22-034626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919122034626/doc4.xml","form_type":"4"}},{"id":2510159,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-16T23:15:41.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":8180,"price":16.04,"value":131207.2,"ownership":{"direct":true},"balance_after":7200,"source":{"system":"sec-edgar","filing":"0001209191-21-064855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919121064855/doc4.xml","form_type":"4"}},{"id":2643657,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T20:18:44.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date and shall vest and become immediately exercisable prior to the effectiveness of a change in control."}],"balance_after":34000,"derivative":{"exercise_price":16,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-21-044949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000120919121044949/doc4.xml","form_type":"4"}},{"id":2678948,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-07T23:25:54.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":10800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 3, 2022 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":10800,"derivative":{"exercise_price":13.06,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":10800},"source":{"system":"sec-edgar","filing":"0001209191-21-038760","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919121038760/doc4.xml","form_type":"4"}},{"id":2678947,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T23:25:54.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":2520,"price":13.05,"value":32886.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of vested RSUs on June 3, 2021. The sales were effected pursuant to a \"sell-to-cover\" arrangement adopted in accordance with Rule 10b5-1 on May 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.02 to $13.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":15380,"source":{"system":"sec-edgar","filing":"0001209191-21-038760","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919121038760/doc4.xml","form_type":"4"}},{"id":2678946,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T23:25:54.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest  on the earlier of (i) June 3, 2022 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":17900,"source":{"system":"sec-edgar","filing":"0001209191-21-038760","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919121038760/doc4.xml","form_type":"4"}},{"id":2967687,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-24T22:46:18.000Z","date":"2020-11-19","kind":"sale","acquired":false,"shares":2500,"price":15.749,"value":39372.5,"ownership":{"direct":true},"balance_after":10700,"source":{"system":"sec-edgar","filing":"0001209191-20-060288","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120060288/doc4a.xml","form_type":"4/A","original_submission_date":"2020-11-23"}},{"id":2969619,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-24T01:26:41.000Z","date":"2020-11-19","kind":"grant","acquired":true,"shares":2500,"price":15.749,"value":39372.5,"ownership":{"direct":true},"balance_after":10700,"source":{"system":"sec-edgar","filing":"0001209191-20-060096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120060096/doc4.xml","form_type":"4"}},{"id":3118293,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-08T21:47:22.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":10800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 4, 2021 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":10800,"derivative":{"exercise_price":15.62,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":10800},"source":{"system":"sec-edgar","filing":"0001209191-20-035065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120035065/doc4.xml","form_type":"4"}},{"id":3118292,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T21:47:22.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest  on the earlier of (i) June 4, 2021 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":13200,"source":{"system":"sec-edgar","filing":"0001209191-20-035065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120035065/doc4.xml","form_type":"4"}},{"id":3123420,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T23:51:06.000Z","date":"2020-06-01","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.94,"expiration_date":"2025-06-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001209191-20-034312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120034312/doc4.xml","form_type":"4"}},{"id":3123419,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T23:51:06.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":1000,"price":16,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-20-034312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120034312/doc4.xml","form_type":"4"}},{"id":3123418,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T23:51:06.000Z","date":"2020-06-01","kind":"exercise","acquired":true,"shares":1000,"price":9.94,"value":9940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001209191-20-034312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120034312/doc4.xml","form_type":"4"}},{"id":3148583,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-15T00:02:11.000Z","date":"2020-05-12","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":1000,"derivative":{"exercise_price":9.94,"expiration_date":"2025-06-08","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-20-029396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120029396/doc4.xml","form_type":"4"}},{"id":3148582,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T00:02:11.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":2500,"price":16,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-20-029396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120029396/doc4.xml","form_type":"4"}},{"id":3148581,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T00:02:11.000Z","date":"2020-05-12","kind":"exercise","acquired":true,"shares":2500,"price":9.94,"value":24850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-20-029396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120029396/doc4.xml","form_type":"4"}},{"id":3172252,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-21T23:09:33.000Z","date":"2020-04-21","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":3500,"derivative":{"exercise_price":9.94,"expiration_date":"2025-06-08","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-20-025311","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120025311/doc4.xml","form_type":"4"}},{"id":3172251,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-21T23:09:33.000Z","date":"2020-04-21","kind":"sale","acquired":false,"shares":2500,"price":16,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-20-025311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120025311/doc4.xml","form_type":"4"}},{"id":3172250,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-21T23:09:33.000Z","date":"2020-04-21","kind":"exercise","acquired":true,"shares":2500,"price":9.94,"value":24850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-20-025311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120025311/doc4.xml","form_type":"4"}},{"id":3222271,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-06T21:39:13.000Z","date":"2020-03-04","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":6000,"derivative":{"exercise_price":9.94,"expiration_date":"2025-06-08","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-20-016942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120016942/doc4.xml","form_type":"4"}},{"id":3222270,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-06T21:39:13.000Z","date":"2020-03-04","kind":"sale","acquired":false,"shares":2500,"price":16,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-20-016942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120016942/doc4.xml","form_type":"4"}},{"id":3222269,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-06T21:39:13.000Z","date":"2020-03-04","kind":"exercise","acquired":true,"shares":2500,"price":9.94,"value":24850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-20-016942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120016942/doc4.xml","form_type":"4"}},{"id":3288288,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-05T22:01:53.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":8500,"derivative":{"exercise_price":9.94,"expiration_date":"2025-06-08","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-20-006976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120006976/doc4.xml","form_type":"4"}},{"id":3288287,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T22:01:53.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":2500,"price":16.23,"value":40575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-20-006976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120006976/doc4.xml","form_type":"4"}},{"id":3288286,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T22:01:53.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":2500,"price":9.94,"value":24850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-20-006976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120006976/doc4.xml","form_type":"4"}},{"id":3317721,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T23:06:56.000Z","date":"2020-01-02","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":11000,"derivative":{"exercise_price":9.94,"expiration_date":"2025-06-08","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-20-002081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120002081/doc4.xml","form_type":"4"}},{"id":3317720,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T23:06:56.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":2500,"price":16.13,"value":40325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-20-002081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120002081/doc4.xml","form_type":"4"}},{"id":3317719,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T23:06:56.000Z","date":"2020-01-02","kind":"exercise","acquired":true,"shares":2500,"price":9.94,"value":24850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-20-002081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919120002081/doc4.xml","form_type":"4"}},{"id":3352335,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-05T00:49:19.000Z","date":"2019-12-02","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.32,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-19-059181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119059181/doc4.xml","form_type":"4"}},{"id":3352334,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T00:49:19.000Z","date":"2019-12-02","kind":"sale","acquired":false,"shares":2500,"price":25.83,"value":64575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-19-059181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119059181/doc4.xml","form_type":"4"}},{"id":3352333,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T00:49:19.000Z","date":"2019-12-02","kind":"exercise","acquired":true,"shares":2500,"price":5.32,"value":13300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-19-059181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119059181/doc4.xml","form_type":"4"}},{"id":3379911,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-05T23:21:53.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":2500,"derivative":{"exercise_price":5.32,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-19-055339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119055339/doc4.xml","form_type":"4"}},{"id":3379910,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-05T23:21:53.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":2500,"price":20.68,"value":51700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-19-055339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119055339/doc4.xml","form_type":"4"}},{"id":3379909,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-05T23:21:53.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":2500,"price":5.32,"value":13300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-19-055339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119055339/doc4.xml","form_type":"4"}},{"id":3398184,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-04T01:19:25.000Z","date":"2019-10-01","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":5000,"derivative":{"exercise_price":5.32,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-19-052482","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119052482/doc4.xml","form_type":"4"}},{"id":3398183,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-04T01:19:25.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":2500,"price":18.21,"value":45525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-19-052482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119052482/doc4.xml","form_type":"4"}},{"id":3398182,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-04T01:19:25.000Z","date":"2019-10-01","kind":"exercise","acquired":true,"shares":2500,"price":5.32,"value":13300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-19-052482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119052482/doc4.xml","form_type":"4"}},{"id":3421534,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-05T21:37:57.000Z","date":"2019-09-03","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":7500,"derivative":{"exercise_price":5.32,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-19-048600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119048600/doc4.xml","form_type":"4"}},{"id":3421533,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-05T21:37:57.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":2500,"price":23.31,"value":58275.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-19-048600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119048600/doc4.xml","form_type":"4"}},{"id":3421532,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-05T21:37:57.000Z","date":"2019-09-03","kind":"exercise","acquired":true,"shares":2500,"price":5.32,"value":13300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-19-048600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119048600/doc4.xml","form_type":"4"}},{"id":3446714,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-05T21:32:29.000Z","date":"2019-08-01","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":10000,"derivative":{"exercise_price":5.32,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-19-044641","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119044641/doc4.xml","form_type":"4"}},{"id":3446713,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-05T21:32:29.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":2500,"price":23.24,"value":58100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-19-044641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119044641/doc4.xml","form_type":"4"}},{"id":3446712,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-05T21:32:29.000Z","date":"2019-08-01","kind":"exercise","acquired":true,"shares":2500,"price":5.32,"value":13300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-19-044641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119044641/doc4.xml","form_type":"4"}},{"id":3467529,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-03T20:04:32.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on July 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":12500,"derivative":{"exercise_price":5.32,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-19-041033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119041033/doc4.xml","form_type":"4"}},{"id":3467528,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-03T20:04:32.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":2500,"price":21.75,"value":54375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on July 1, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-19-041033","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119041033/doc4.xml","form_type":"4"}},{"id":3467527,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-03T20:04:32.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":2500,"price":5.32,"value":13300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on July 1, 2019."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-19-041033","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119041033/doc4.xml","form_type":"4"}},{"id":3498528,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T22:01:55.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 4, 2020 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":20.44,"expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-19-035222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119035222/doc4.xml","form_type":"4"}},{"id":3498527,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T22:01:55.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest  on the earlier of (i) June 4, 2020 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-19-035222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919119035222/doc4.xml","form_type":"4"}},{"id":3899633,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T20:32:51.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted to the reporting person pursuant to the issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on June 6, 2019, subject to the reporting person's continued service as a director through such date."}],"balance_after":18000,"derivative":{"exercise_price":16.07,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-18-036698","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919118036698/doc4.xml","form_type":"4"}},{"id":4273295,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":40807,"kind":"person","name":"Ives Jeffrey L.","position":1,"cik":"0001614096","reported_name":"Ives Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-23T22:35:07.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted to the reporting person pursuant to the issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on June 21, 2018, subject to the reporting person's continued service as a director through such date."}],"balance_after":15000,"derivative":{"exercise_price":19.5,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-041748","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000120919117041748/doc4.xml","form_type":"4"}}]}